Treatment with icodec, a once-a-week basal insulin injection, reduced glycated hemoglobin levels by similar amounts as degludec, a daily basal insulin injection, at about 6 months, according to results from a phase 3 trial involving 582 adult participants with type 1 diabetes. All participants in the international study also received short-acting insulin with meals.
Source: JAMA Online First